321 Launch: Space news you may have missed over the past week (Jan. 5)

Florida's Space Coast hit a new milestone with 109 orbital launches in 2025 (101 flown on Florida-based Falcon 9 rockets), and SpaceX commenced 2026 operations with the Starlink 6-88 Falcon 9 launch on Jan. 4. In industry developments, L3Harris won up to $843 million from the Space Development Agency to build and integrate 18 infrared missile-tracking satellites in Palm Bay, Blue Origin faces a Jan. 30 public DEP meeting on its Merritt Island wastewater permit renewal, and Max Space is setting up manufacturing at Kennedy for expandable Kevlar-like space habitats.

Analysis

Market structure: Rapidly rising Cape Canaveral launch cadence (109 launches in 2025) plus large SDA awards concentrate benefits on prime defense/aero suppliers (LHX, RTX, NOC) and composite/materials makers; infrastructure and test-service providers (range ops, integration) gain pricing power for scarce pad/time slots. Smaller launch integrators and commercial payload suppliers face margin pressure as SpaceX internalizes more stack components and reusability lowers per‑launch service revenue. Cross-asset: higher government aerospace capex is mildly inflationary for specialty metals/composites (2–5% demand lift next 12–24 months) and supportive for defensedealer credit while reducing idiosyncratic equity volatility in primes.

Risk assessment: Tail risks include permit/regulatory delays (Blue Origin wastewater hearing could delay New Glenn manufacturing ramp by 6–18 months), supply-chain bottlenecks for infrared sensors or composite domes, and a political shift reducing SDA funding (10–20% cut). Short-term (days–weeks) volatility driven by permit headlines; medium-term (3–12 months) execution risk on L3Harris production scaling; long-term (2–5 years) secular demand tied to geopolitical tensions. Hidden dependencies: local workforce constraints in Florida and single-site concentration (Palm Bay) create outsized operational risk if disrupted.

Trade implications: Direct: establish a 2–4% long position in LHX targeting +20% upside over 12 months (stop -10%). Use ITA (A&D ETF) to gain broader exposure (3–5% overweight vs benchmark) while shorting a small-cap commercial launcher ETF or index by 1–2% to hedge reusability risk. Options: buy LHX 12-month call spread (e.g., 12-month 10–15% OTM) to cap cost; consider selling premium into any 10%+ pop.

Contrarian angles: Consensus overweights launch cadence as linear revenue for suppliers — underestimate SpaceX verticalization reducing outsourced spend by perhaps 30% over 3 years. Conversely, large SDA contracts create sticky revenue: if LHX execution is clean, upside could be underappreciated. Historical parallel: post-award rallies (eg. early 2010s missile programs) faded when execution lagged; therefore size positions with execution triggers (quarterly backlog growth >5%). Unintended: local permit fights could concentrate regulatory risk across private space peers, making selective regional exposure important.

Key Decisions for Investors

• Establish a 2–4% long position in LHX (L3Harris) within 2–6 weeks, target +20% upside over 12 months, set a hard stop at -10% and trim 50% of the position if quarterly production/backlog growth <+5%.
• Overweight Aerospace & Defense via ITA (iShares U.S. Aerospace & Defense ETF) by 3–5% of portfolio vs benchmark for 6–12 months to capture SDA/DoD spending; fund by reducing general industrials exposure by the same amount.
• Implement a hedge: short 1–2% notional exposure to small-cap commercial launch or 'NewSpace' equities (or use a thematic ETF proxy) to offset risk of vertical integration by SpaceX; reduce if SpaceX outsourcing signals appear (vendor awards increase).
• Buy LHX 12‑month call spread (e.g., ~10–15% OTM) sizing to 0.5–1% portfolio risk to leverage contract wins while capping premium; close if implied vol rises >30% or stock rallies >20%.